Abstract:Background:Mixed lineage kinase 3 (MLK3) is a member of a serine/threonine MAP3K family, and it has been demonstrated to play critical roles in various biological activities and disease progression. Previous studies showed that impaired skeletal mineralization and spontaneous tooth fracture in the MLK3-deficient mice, suggesting MLK3 actively participated in the bone formation. However, the detailed function and underlying mechanisms remain obscure.Methods:The MLK3 knockout (KO) mouse was applied in the present study, and multi-omics were performed to compare the metabolites and gene expression between wild type (WT) and KO mice. The bone fracture model was successfully established, and the healing process was evaluated by X-ray, micro-CT examination, histomorphometry and immunohistochemistry (IHC) staining. On the other hand, the effects of MLK3 on osteogenic differentiation were assessed by alkaline phosphatase (ALP) activity, Alizarin red S (ARS) staining and qRT-PCR examination. Finally, the downstream signaling pathways were screened out by RNA-sequencing (RNA-seq) and then validated by Western blotting.Results:In the present study, imbalanced bone metabolism was observed in these MLK3 KO mice, suggesting MLK3 may participate in bone development. Moreover, MLK3 -/- mice displayed abnormal bone tissues, impaired bone quality, and delayed fracture healing. Further investigation showed that the inhibition of MLK3 attenuated osteoblast differentiation in vitro. According to the RNA-seq data, MAPK signaling was screened out to be a downstream pathway, and its subfamily members extracellular signal-regulated kinase (ERK), p38 and Jun N-terminal protein kinase (JNK) were subjected to Western blotting examination. The results revealed that although no differences in their expression were observed between MSCs derived from WT and KO mice, their phosphorylated protein levels were all suppressed in MLK3 -/- MSCs.Conclusion:In conclusion, our results demonstrated that loss of MLK3 suppressed osteoblast differentiation and delayed bone formation via influencing metabolism and disturbing MAPK signaling.The translational potential of this article:The findings based on the current study demonstrated that MLK3 promoted osteogenesis, stimulated new bone formation and facilitated fracture healing, suggesting that MLK3 may serve as a potential therapeutic target for bone regeneration. MLK3 activator therefore may be developed as a therapeutic strategy for bone fracture.

Dnmt3b ablation affects fracture repair process by regulating apoptosis

Dnmt3b ablation impairs fracture repair through upregulation of Notch pathway

Loss of Bcl-3 delays bone fracture healing through activating NF-κB signaling in mesenchymal stem cells

FGFR3 deficient mice have accelerated fracture repair

Effect of the Interaction Between MiR-200b-3p and DNMT3A on Cartilage Cells of Osteoarthritis Patients.

P094 Lack of DNA methyltransferase DNMT3A in fibroblasts impairs cell growth and wound healing

Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells

Unraveling IGFBP3-mediated m6A modification in fracture healing

MicroRNA-185 Inhibits the Growth and Proliferation of Osteoblasts in Fracture Healing by Targeting PTH Gene Through Down-Regulating Wnt/β -Catenin Axis: in an Animal Experiment.

Suppression of DNMT2/3 by proinflammatory cytokines inhibits CtBP1/ 2-dependent genes to promote the occurrence of atrophic nonunion

MMP9 regulates the cellular response to inflammation after skeletal injury

Fracture healing is delayed in the absence of gasdermin signaling

Transcriptome Analysis of Dnmt3l Knock-Out Mice Derived Multipotent Mesenchymal Stem/Stromal Cells During Osteogenic Differentiation

Decreased BMP2 signal in GIT1 knockout mice slows bone healing

DDIT3 deficiency accelerates bone remodeling during bone healing by enhancing osteoblast and osteoclast differentiation through ULK1-mediated autophagy

Knockdown of Ggps1 in chondrocyte expedites fracture healing by accelerating the progression of endochondral ossification in mice

Long noncoding RNA XIST modulates microRNA-135/CREB1 axis to influence osteogenic differentiation of osteoblast-like cells in mice with tibial fracture healing

MLK3 Silence Suppressed Osteogenic Differentiation and Delayed Bone Formation Via Influencing the Bone Metabolism and Disturbing MAPK Signaling

Modulation of Wnt signaling influences fracture repair

Deletion of Runx1 in osteoclasts impairs murine fracture healing through progressive woven bone loss and delayed cartilage remodeling

Anti-DKK1 Antibody Promotes Bone Fracture Healing Through Activation of Β-Catenin Signaling.